A modified in vitro clot lysis assay predicts outcomes and safety in acute ischemic stroke patients undergoing intravenous thrombolysis

Abstract The outcome of intravenous thrombolysis using recombinant tissue plasminogen activator (rt-PA) is only favorable in ≈ 40% of acute ischemic stroke (AIS) patients. Moreover, in ≈ 6–8% of cases, intracerebral hemorrhage (ICH) develops. We tested whether a modification of clot lysis assay (CLA...

Full description

Saved in:
Bibliographic Details
Main Authors: Rita Orbán-Kálmándi, István Szegedi, Ferenc Sarkady, István Fekete, Klára Fekete, Nikolett Vasas, Ervin Berényi, László Csiba, Zsuzsa Bagoly
Format: article
Language:EN
Published: Nature Portfolio 2021
Subjects:
R
Q
Online Access:https://doaj.org/article/af99f94ee0064776ab13f80afb582255
Tags: Add Tag
No Tags, Be the first to tag this record!